The @-@-fold antigen-sparing adjuvanted pandemic influenza vaccine demonstrated superior and clinically important prevention of A ( H@N@ ) pdm@ infection , compared with nonadjuvanted vaccine , with no observed increase in medically attended or serious adverse events .